These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4414651)

  • 1. Metabolism of hexamethylmelamine-ring-14C in rats and man.
    Worzalla JF; Kaiman BD; Johnson BM; Ramirez G; Bryan GT
    Cancer Res; 1974 Oct; 34(10):2669-74. PubMed ID: 4414651
    [No Abstract]   [Full Text] [Related]  

  • 2. N-demethylation of the antineoplastic agent hexamethylmelamine by rats and man.
    Worzalla JF; Johnson BM; Ramirez G; Bryan GT
    Cancer Res; 1973 Nov; 33(11):2810-5. PubMed ID: 4748436
    [No Abstract]   [Full Text] [Related]  

  • 3. Absorption, tissue distribution, and excretion of the anti-neoplastic agent guanazole in the rat.
    Musa MN; Lower GM; Welling PG; Johnson BM; Kaiman BD; Bryan GT
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):497-512. PubMed ID: 4824824
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology of a new triazine antifolate in mice, rats, dogs, and monkeys.
    Cashmore AR; Skeel RT; Makulu DR; Gralla EJ; Bertino JR
    Cancer Res; 1975 Jan; 35(1):17-22. PubMed ID: 803254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of 14C-dimethothiazine. I. Distribution and excretion following oral administration in the dog and rat.
    Lewellen OR; Templeton R
    Adv Biochem Psychopharmacol; 1974; 9(0):213-27. PubMed ID: 4151920
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetic studies on 14C-azapropazone dihydrate in the rat].
    Klatt L; Koss FW
    Arzneimittelforschung; 1973 Jul; 23(7):913-9. PubMed ID: 4800443
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetic studies on 14C-azapropazone dihydrate in man].
    Klatt L; Koss FW
    Arzneimittelforschung; 1973 Jul; 23(7):920-1. PubMed ID: 4800444
    [No Abstract]   [Full Text] [Related]  

  • 8. The metabolism of tamoxifen (I.C.I. 46,474). I. In laboratory animals.
    Fromson JM; Pearson S; Bramah S
    Xenobiotica; 1973 Nov; 3(11):693-709. PubMed ID: 4361333
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma levels and urinary excretion of hexamethylmelamine following oral administration to human subjects with cancer.
    Bryan GT; Worzalla JF; Gorske AL; Ramirez G
    Clin Pharmacol Ther; 1968; 9(6):777-82. PubMed ID: 5721980
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotransformation of 2-hydroxynicotinic acid: N-riboside formation in vivo.
    Schwartz MA; Kolis SJ; Williams TH; Gabriel TF; Toome V
    Drug Metab Dispos; 1973; 1(3):557-64. PubMed ID: 4149449
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolism of 1-n-butyl-5,5-diethylbarbituric acid (N-n-butyl barbital) in the rat.
    Vore M; Sweetman BJ; Bush JT
    J Pharmacol Exp Ther; 1974 Aug; 190(2):384-94. PubMed ID: 4449048
    [No Abstract]   [Full Text] [Related]  

  • 12. Irreversible enzyme inhibitors. CLXXIV. Metabolism of 4-(p-(4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)hydrocinnamido)-o-toluenesulfonyl fluoride (NSC-113423), an active-site-directed irreversible inhibitor of dihydrofolic reductase.
    Ryan AJ; Vermeulen NM; Baker BR
    J Med Chem; 1970 Nov; 13(6):1140-2. PubMed ID: 5479853
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolism of tinidazole in the rat and dog.
    Wood BA; Rycroft D; Monro AM
    Xenobiotica; 1973 Dec; 3(12):801-12. PubMed ID: 4786681
    [No Abstract]   [Full Text] [Related]  

  • 14. Butaperazine dimaleate metabolism.
    Bruce RB; Turnbull LB; Newman JH; Kinzie JM; Morris PH; Pinchbeck FM
    Xenobiotica; 1974 Apr; 4(4):197-207. PubMed ID: 4152571
    [No Abstract]   [Full Text] [Related]  

  • 15. The fate of N-trichloro(14C)methylthio-4-cyclohexene-1,2-dicarboximide((14C)captan) in the rat.
    DeBaun JR; Miaullis JB; Knarr J; Mihailovski A; Menn JJ
    Xenobiotica; 1974 Feb; 4(2):101-19. PubMed ID: 4828796
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism and disposition of Baker's antifolate (NSC-139105), ftorafur (NSC-148958), and dichloroallyl lawsone (NSC-126771) in man.
    Loo TL; Benjamin RS; Lu K; Benvenuto JA; Hall SW; McKelvey EM
    Drug Metab Rev; 1978; 8(1):137-50. PubMed ID: 363378
    [No Abstract]   [Full Text] [Related]  

  • 17. The metabolism of phenylbutazone in the rat.
    Bakke OM; Draffan GH; Davies DS
    Xenobiotica; 1974 Apr; 4(4):237-54. PubMed ID: 4603132
    [No Abstract]   [Full Text] [Related]  

  • 18. Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans.
    Ames MM; Powis G; Kovach JS; Eagan RT
    Cancer Res; 1979 Dec; 39(12):5016-21. PubMed ID: 115586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, metabolism and excretion of 14C-griseofulvin in man.
    Lin CC; Magat J; Chang R; McGlotten J; Symchowicz S
    J Pharmacol Exp Ther; 1973 Nov; 187(2):415-22. PubMed ID: 4748557
    [No Abstract]   [Full Text] [Related]  

  • 20. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.